Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
Offit K, Bradbury A, Storm C, Merz JF, Noonan KE, Spence R.
Offit K, et al. Among authors: spence r.
J Clin Oncol. 2013 Jul 20;31(21):2743-8. doi: 10.1200/JCO.2013.49.7388. Epub 2013 Jun 13.
J Clin Oncol. 2013.
PMID: 23766521
Free PMC article.
Although the outcomes are uncertain, it is suggested here that the Supreme Court decision will have few immediate effects on oncology practice or research but may have more significant long-term impact. The Federal Circuit court has already rejected Myriad's broad diagnost …
Although the outcomes are uncertain, it is suggested here that the Supreme Court decision will have few immediate effects on oncology practi …